Highly Divergent Type 2 and 3 Vaccine-derived Polioviruses Isolated from Sewage in Tallinn, Estonia

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2013 Sep 20

PMID 24049178

Citations 10

Authors

Haider Al-Hello

Jaume Jorba

Soile Blomqvist

Riina Raud

Olen Kew

Merja Roivainen

Affiliations

Soon will be listed here.

Abstract

Highly divergent vaccine-derived polioviruses (VDPVs) have been isolated from sewage in Tallinn, Estonia, since 2002. Sequence analysis of VDPVs of serotypes 2 and 3 showed that they shared common noncapsid region recombination sites, indicating origination from a single trivalent oral polio vaccine dose, estimated to have been given between 1986 and 1998. The sewage isolates closely resemble VDPVs chronically excreted by persons with common variable immunodeficiency, but no chronic excretors have yet been identified in Estonia.

Citing Articles

Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage.

Korotkova E, Prostova M, Gmyl A, Kozlovskaya L, Eremeeva T, Baikova O Viruses. 2020; 12(9).

PMID: 32883046 PMC: 7552002. DOI: 10.3390/v12090970.

Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters.

Kalkowska D, Pallansch M, Thompson K Epidemiol Infect. 2019; 147:e295.

PMID: 31647050 PMC: 6813650. DOI: 10.1017/S095026881900181X.

The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda.

Nanteza M, Bakamutumaho B, Kisakye A, Namuwulya P, Bukenya H, Katushabe E Virol J. 2018; 15(1):77.

PMID: 29699577 PMC: 5922010. DOI: 10.1186/s12985-018-0990-y.

Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Shaw J, Jorba J, Zhao K, Iber J, Chen Q, Adu F J Virol. 2018; 92(9).

PMID: 29444940 PMC: 5899205. DOI: 10.1128/JVI.01949-17.

Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Tebbens R, Zimmermann M, Pallansch M, Thompson K Food Environ Virol. 2017; 9(4):361-382.

PMID: 28687986 PMC: 7879701. DOI: 10.1007/s12560-017-9314-4.

References

. Progress toward eradication of polio--worldwide, January 2011-March 2013. MMWR Morb Mortal Wkly Rep. 2013; 62(17):335-8. PMC: 4604928. View

COCKBURN W, Drozdov S . Poliomyelitis in the world. Bull World Health Organ. 1970; 42(3):405-17. PMC: 2427528. View

Ren R, Moss E, Racaniello V . Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol. 1991; 65(3):1377-82. PMC: 239915. DOI: 10.1128/JVI.65.3.1377-1382.1991. View

Burns C, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N . Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013; 87(9):4907-22. PMC: 3624331. DOI: 10.1128/JVI.02954-12. View

Kew O, Sutter R, de Gourville E, Dowdle W, Pallansch M . Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005; 59:587-635. DOI: 10.1146/annurev.micro.58.030603.123625. View

Joffret M, Jegouic S, Bessaud M, Balanant J, Tran C, Caro V . Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children. J Infect Dis. 2012; 205(9):1363-73. DOI: 10.1093/infdis/jis204. View

Yong P, Thaventhiran J, Grimbacher B . "A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?. Adv Immunol. 2011; 111:47-107. DOI: 10.1016/B978-0-12-385991-4.00002-7. View

Shulman L, Manor Y, Sofer D, Handsher R, Swartz T, Delpeyroux F . Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS One. 2006; 1:e69. PMC: 1762338. DOI: 10.1371/journal.pone.0000069. View

. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011. MMWR Morb Mortal Wkly Rep. 2011; 60(25):846-50. View

10.

Toyoda H, Kohara M, Kataoka Y, Suganuma T, Omata T, Imura N . Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol. 1984; 174(4):561-85. DOI: 10.1016/0022-2836(84)90084-6. View

11.

Cernakova B, Sobotova Z, Rovny I, Blahova S, Roivainen M, Hovi T . Isolation of vaccine-derived polioviruses in the Slovak Republic. Eur J Clin Microbiol Infect Dis. 2005; 24(6):438-9. DOI: 10.1007/s10096-005-1331-9. View

12.

Khetsuriani N, Prevots D, Quick L, Elder M, Pallansch M, Kew O . Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis. 2003; 188(12):1845-52. DOI: 10.1086/379791. View

13.

Martin J, Dunn G, Hull R, Patel V, Minor P . Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol. 2000; 74(7):3001-10. PMC: 111798. DOI: 10.1128/jvi.74.7.3001-3010.2000. View

14.

Jorba J, Campagnoli R, De L, Kew O . Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol. 2008; 82(9):4429-40. PMC: 2293050. DOI: 10.1128/JVI.02354-07. View

15.

Minin V, Dorman K, Fang F, Suchard M . Dual multiple change-point model leads to more accurate recombination detection. Bioinformatics. 2005; 21(13):3034-42. DOI: 10.1093/bioinformatics/bti459. View

16.

Yang C, Chen H, Jorba J, Sun H, Yang S, Lee H . Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol. 2005; 79(20):12623-34. PMC: 1235840. DOI: 10.1128/JVI.79.20.12623-12634.2005. View

17.

Minor P . Antigenic structure of picornaviruses. Curr Top Microbiol Immunol. 1990; 161:121-54. DOI: 10.1007/978-3-642-75602-3_5. View

18.

Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H . Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008; 137(1):168-72. DOI: 10.1016/j.virusres.2008.07.006. View

19.

. Evaluating surveillance indicators supporting the Global Polio Eradication Initiative, 2011-2012. MMWR Morb Mortal Wkly Rep. 2013; 62(14):270-4. PMC: 4604901. View

20.

DeVries A, Harper J, Murray A, Lexau C, Bahta L, Christensen J . Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med. 2011; 364(24):2316-23. DOI: 10.1056/NEJMoa1008677. View